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Fast-scan cyclic voltammetry is a unique technique for sampling dopamine concentration in the brain
of rodents in vivo in real time. The combination of in vivo voltammetry with single-unit electrophysi-
ological recording from the same microelectrode has proved to be useful in studying the relationship
between animal behavior, dopamine release and unit activity. The instrumentation for these exper-
iments described here has two unique features. First, a 2-electrode arrangement implemented for
voltammetric measurements with the grounded reference electrode allows compatibility with electro-
physiological measurements, iontophoresis, and multielectrode measurements. Second, we use minia-
turized electronic components in the design of a small headstage that can be fixed on the rat’s head
and used in freely moving animals. © 2011 American Institute of Physics. [doi:10.1063/1.3610651]
I. INTRODUCTION
In vivo fast-scan cyclic voltammetry (FSCV) is a
powerful technique that allows real time measurement of
electrochemically active biomolecules in both slices and the
intact animal brain with nanomolar sensitivity.1 Initially it
was developed for the detection of biogenic amines, specifi-
cally dopamine, with carbon-fiber microelectrodes. However,
in the last decade, the field has witnessed significant growth
in the number of analytes that can be measured with FSCV.
Detection of adenosine,2 norepinephrine,3 oxygen,4 pH 5 and
serotonin6 in brain in vivo have been demonstrated.
Dopaminergic neurons are involved in control of motor
activity, learning and motivation. FSCV has been used to de-
tect dopamine release at the terminal fields of dopaminergic
neurons in the striatum during such behaviors.7 Technical
advances in the construction of miniaturized and highly
sensitive electronics as well as improvement in chemical
sensitivity of the microelectrodes8, 9 have made it possible
to measure endogenous dopamine release in freely moving
animals routinely, allowing the study of behavior associated
with this release.
While electrochemical detection of neurotransmitter re-
lease in behaving animals is a relatively new invention, the
recording of single-units, which was pioneered in the early
1950s, is a more traditional method for investigation of brain
function in real time.10 This method is based on recording
changes in extracellular potential induced by the firing of
single neurons. Sharp microelectrodes, with megaohm resis-
tance made of either glass pipettes, insulated metal wires or
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carbon-fiber microelectrodes are traditionally used for these
recordings.11 Multiple cells can be recorded with a single mi-
croelectrode. Today, single-unit recording is used in behaving
animals and with microelectrode arrays that allow for record-
ing of ensembles of hundreds of neurons.12
About thirty years ago, Julian Millar and co-workers de-
veloped instrumentation to perform FSCV and single-unit
measurements simultaneously in brain preparations using a
single carbon-fiber microelectrode.13, 14 Several advantages
result from the use of a single electrode for both measure-
ments instead of separate electrodes,15 including the ability
to measure action potentials from the same cells that are be-
ing influenced by local neurotransmitter release and the mini-
mization of brain tissue damage. The combined electrochemi-
cal/electrophysiological technique (Echem/Ephys) allows the
investigation of both presynaptic and postsynaptic events si-
multaneously. However, the early experiments were restricted
to brain slices and anesthetized animals. The original instru-
mentation was unsuitable for experiments in behaving ani-
mals.
In the ensuing twenty years there has been consider-
able refinement of electronic components pertinent to these
experiments, including miniaturized electronic components
and custom printed-circuit-board technology. We have taken
advantage of these advancements to design a combined
Echem/Ephys instrument for behavioral experiments in freely
moving rats. Miniature headstages have been designed that
can be mounted directly on the rat’s head. Also, the tradi-
tional 3-electrode potentiostat has been reduced to a simpler
2-electrode potentiostat. Unique insight into brain processing
during behavior has been obtained with this instruments as
described in prior publications.16, 17
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II. DESIGN
A. Overview of setup for combined
behavioral experiments
A block diagram of the overall system is shown in Fig. 1.
Typically, a rat (not shown) is placed in a behavioral chamber
(Med Associates Inc, St Albans, VT) with levers, house lights
and an audio speaker that are used as behavioral cues dur-
ing experiments. The operant box is located inside of a Fara-
day cage, which shields the animal and sensitive components
from extraneous electric fields. A set of rotating contacts (slip
rings) contained in a swivel (Crist Instrument Co Inc, Hager-
stown, MD) is fixed on the top of the behavioral chamber. It
allows all of the electrical signals to be passed to and from
a tethered headstage located on the animal’s head and allows
the animal free movement throughout the box. The swivel also
provides one fluid port that can be used for administration of
drugs. The headstage connects through the swivel to a mod-
ular universal electrochemical instrument (UEI) mainframe
which contains ancillary circuitry for headstage operation and
processing.
Before the experiment, surgery is performed on the rat
under general anesthesia. Holes are drilled in the skull to
allow electrode placement in specific brain regions accord-
ing to stereotaxic coordinates.18 For dopamine measurements,
a bipolar stimulating electrode is implanted in the ventral
tegmental area or medial forebrain bundle, allowing stim-
ulation of dopaminergic neurons. A guide cannula for the
carbon-fiber microelectrode is implanted above the nucleus
accumbens, the site of dopaminergic terminals. A Ag/AgCl
reference electrode is implanted contralaterally. The animal
is allowed to recover for at least three days before experi-
ments. During recording, the carbon-fiber microelectrode is
lowered into the nucleus accumbens of an awake animal
using a custom made manipulator. The manipulator should
FIG. 1. (Color online) Setup for combined freely moving Echem/Ephys ex-
periments. The behavioral chamber (B) is located inside grounded Faraday
cage (A). Headstage (D) is fixed on rat’s head and connected through a ro-
tating swivel (C) with the UEI potentiostat (E). The UEI is interfaced with
breakout box (F) though front panel BNC connectors. The voltammetric part
of the experiment is controlled by a PC (G) with NI cards that are connected
to the breakout box. The electrophysiological signal is high-pass filtered (M)
and sampled with NI card on the separate PC (H). The interface of the be-
havioral chamber components (levers, lights and tones, K) is controlled with
Med Associates control module (L) that is connected to a third computer (not
shown).
be grounded to prevent interference from accumulated static
charge during voltammetric measurements. A triangular volt-
age excursion of –0.4 V to 1.3 V at a scan rate of 400 V/sec is
applied at regular frequency for cyclic voltammogram gener-
ation. For electrochemical experiments, the triangular wave
is repeated at 10 Hz, termed the CV frequency (CVF), and
voltammograms are acquired in ∼10 ms. In the combined
Ephys/Echem mode, the CV frequency is 5 Hz. The 200 ms
delay between cyclic voltammograms is implemented for two
reasons. First, it increases the sampling window for electro-
physiological data. Second, a longer holding period between
cyclic voltammograms facilitates dopamine adsorption, pro-
moting sensitivity.8 Note that in the combined mode the po-
tential of the carbon-fiber microelectrode is allowed to float,
and adsorption of dopamine occurs to a lesser extent. Nev-
ertheless, response to dopamine for combined technique is
around 60% of response observed with traditional in vivo
voltammetry when electrode is held for 100 milliseconds at
negative potential between scans.16
The voltammetric experiment, as well as delivery of elec-
trical stimulations, is controlled by a computer running a
locally written LABVIEW based program along with three
National Instruments PCI DAQ cards (National Instruments,
Austin, TX). The cards employed are the NI-6251 (updated
version of NI-6052E), which is used for generation of the
voltammetric ramp and data acquisition; the NI-6711, which
is used for the output of the main clock (CVF), synchroniza-
tion and generation of stimulation pulses; and the NI-6601,
which is used to acquire digital signals associated with the
behavior from Med Associates SmartCtrl module (Med As-
sociates Inc, St Albans, VT).
The UEI has a switching module that uses the CVF clock
to alternate between Echem and Ephys modes of operation
(Fig. 2). There are five CMOS switches with a total of four
switches located in the switching module and one switch lo-
cated on the headstage.
The electrophysiology signal from the UEI is fed to a
Grass model AM 10 high-pass filter and an audio speaker
(Grass Product Group, Astro-Med Inc, West Warwick, RI) to
provide audio output of neuronal activity. The same signal is
also filtered using a Dual Channel Butterworth/Bessel Model
3382 8-pole filter (Krohn-Hite Corporation, Brockton, MA)
and is fed to a computer equipped with an NI-6040 DAQ card
and Plexon software (Plexon Inc, Dallas, TX) for unit record-
ing and analysis.
B. Design of potentiostat for in vivo voltammetry
For FSCV measurements, 2-electrode circuitry is used.
In this configuration, a voltage ramp is applied between a pair
of electrodes and the resulting current is measured. This dif-
fers from the traditional 3-electrode design in which oxida-
tion/reduction takes place at the working electrode according
to the voltage applied to the auxiliary electrode. In some sys-
tems where the resistance of the media is high, there can be
a substantial difference between the desired voltage and the
voltage that appears at the working electrode (due to the iR
drop in the solution). Therefore, a third reference electrode is
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FIG. 2. Block diagram of UEI potentiostat and headstage schematic. Left portion is the headstage that is connected via a DB-25 connector to the UEI chassis
(right panel). The reference electrode (REF) is connected to ground. The output from the working electrode (WE) alternates between FSCV (Echem) and
electrophysiology (Ephys) preamplifiers with the switch (SW1). Afterwards, signals are sent to a switching module where in Echem mode SW2 is used to
connect the headstage to the Echem Amplifier. Switch SW3 grounds input to the Ephys amplifier and switch SW4 grounds the output from the Ephys amplifier
to prevent overload. SW5 is used to ground the non-inverting input of the I/E converter when the system operates in Ephys mode. Headstage is connected to UEI
via DB-25 cable.
utilized to sense the actual voltage in proximity to the working
electrode and, through feedback circuitry, to increase the volt-
age applied to the auxiliary electrode to offset the iR drop.19
However, in this application the 2-electrode scheme is advan-
tageous. First, the hazard of accidental electrical shocks to the
experimental animal from the auxiliary electrode is avoided.
Second, the 3-electrode scheme is unnecessary for compen-
sating iR drop with microelectrodes. The resistance of the
electrochemical cell with a cylindrical microelectrode is pro-
portional to the logarithm of the distance between the work-
ing and auxiliary electrodes.20, 21 This means that the major-
ity of the potential drop occurs immediately adjacent to the
microelectrode making it difficult to place a reference elec-
trode in close proximity without causing damage in the mea-
surement region. In addition, brain tissue has a relatively high
conductivity (ionic strength is greater than 0.1 M), so the iR
drop for microelectrodes is small and does not significantly
affect the value of the applied potential. This small error can
be further reduced by in vitro calibration in solution with re-
sistivity similar to that of the brain microenvironment.22 Ad-
ditionally, as the triangular wave scan rate increases, the auxil-
iary electrode introduces complex impedance to the circuitry.
This affects the gain and phase margins of potentiostatic cir-
cuitry which can cause stability problems leading to undesir-
able oscillations.23
In both the 3-electrode and 2-electrode potentiostatic
methods, the Ag/AgCl electrode is referred to as the “refer-
ence electrode”. However, it actually serves different func-
tions in each method. In the 3-electrode scheme, the reference
electrode is used to sense the potential near the working elec-
trode, and because it is followed by a high input impedance
amplifier, no current flows through the reference electrode.
Current flow is from the auxiliary electrode to the work-
ing electrode in the 3-electrode method. In the 2-electrode
method, current flows from the working electrode to the refer-
ence electrode which is at ground potential, so the “reference
electrode” is really performing the duty of the auxiliary elec-
trode. However, to preserve consistency with the literature,
the Ag/AgCl will be called “reference electrode” throughout
this manuscript.
Normally, two-electrode measurements employ an oper-
ational amplifier (op-amp) as a current to voltage (I-E) con-
verter with the non-inverting input at ground potential and the
inverting input connected to the working electrode. The ramp
signal is inverted and then applied directly to the reference
electrode and the current is measured by the I-E converter.
This design is used in EI-400 potentiostat (ESA Biosciences
Inc, Chelmsford, MA). The main drawback of this approach
is that it makes it difficult to use additional current sources
and sinks in the same preparation because their current will
flow to the working electrode. Also, the working electrode is
held at ground potential instead of at the desired potential due
to the virtual ground present at the input of the op-amp.
In the UEI, the headstage consists of an operational am-
plifier in I-E mode with the ramp signal applied to the non-
inverting input while the working electrode is connected to
the inverting input. In this case, the voltage at the microelec-
trode follows the voltage applied to the non-inverting input of
the amplifier. At the same time, the current that flows between
the working and the reference electrodes (as a result of the ap-
plied voltage) is summed at the inverting input and adds to the
voltage seen at the output of the amplifier. The output voltage
then becomes
VO = − (IIN × RF) + VR, (1)
where Vo is output voltage, IIN is input current, RF is feedback
resistor and VR is ramp voltage. Since the output Vo has the
added ramp voltage, VR, and it should be subtracted in hard-
ware or software to produce a signal related to the voltammet-
ric current.
The realization of this 2-electrode approach proved to
be beneficial since it allowed for a number of experimental
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FIG. 3. Schematic circuitries for headstages with iontophoresis, analog
background subtraction and multiple electrode recording. For the ion-
tophoretic setup, an additional current source for drug ejection is added to the
circuitry (A). For analog-background subtraction, an additional input through
the gain resistor is added to the summing point of the amplifier (B). Record-
ings with multiple independent microelectrodes can be performed by using a
separate amplifier for each microelectrode (C).
setups that are complimentary with traditional FSCV experi-
ments in animals. For example, iontophoresis which is quan-
titative drug delivery technique24 is compatible with pre-
sented potentiostat design because introduction of extra cur-
rent source in iontophoretic barrel does not disturb mea-
suring of electrochemical current on the working electrode
(Fig. 3(a)). All of the currents (electrochemical and ion-
tophoretic) flow to the reference electrode.
The use of fast scan rates leads to high background cur-
rents, which are significantly higher than the current for ox-
idation of the analyte (i.e. dopamine). Traditionally, numeri-
cal background subtraction in software is used to remove this
current. However, analog-background subtraction is possible
and it has number of advantages such as an increase in ampli-
fier dynamic range, a decrease in digitization noise and com-
pensation for background drift. Recently, analog background
subtraction was realized by a simple modification to the head-
stage circuitry.25 An additional input for inverted background
current was added to the summing point of the amplifier
(Fig. 3(b)). The background current is recorded in the absence
of analyte and stored in the computer. During measurements,
a DAC is used to generate the inverted background current,
which is sent through the second gain resistor and subtracted
from the current flowing from the working electrode.
Another important advantage of the UEI is the abil-
ity to execute measurements with multiple independently
controlled microelectrodes. In this setup multiple opera-
tional amplifiers can be used with a separate amplifier
for each microelectrode and the same grounded reference
(Fig. 3(c)). The same voltammetric ramp can be applied to
all microelectrodes26, 27 to sample dopamine in different brain
regions simultaneously. Alternatively, different voltammetric
ramps can be applied to each electrode each of which is
suited for specific analyte such as dopamine and oxygen or
5-hydroxytryptamine.28
C. Headstage design for combined FSCV
and electrophysiological measurements in freely
moving animals
Typical stand-alone electrophysiological measurement of
single-unit impulses is carried out with a simple voltage fol-
lower amplifier, which outputs the potential between a pair of
electrodes. In our case, the measurement is between the same
electrodes as that used for FSCV, that is, between the carbon
fiber microelectrode and the Ag/AgCl electrode. Because the
input impedance of the buffer amplifier is extremely high, the
signal amplitude is unaffected by relatively high impedance
of the electrodes.
To perform simultaneous measurements in freely moving
animals, a miniaturized headstage has been designed (Fig. 4).
The headstage is designed to fit on the rat’s head without af-
fecting its behavior and it weighs just 2.5 g. A DB-25 connec-
tor attaches to the swivel in the behavioral chamber which,
in turn, connects to the UEI mainframe. The main feature
of the headstage is the surface-mount OPA 2604AU (Texas
Instruments, Dallas, TX) dual operational amplifier (Fig. 5).
One amplifier on this chip (U2a) functions as a high gain cur-
rent transducer. The other one (U2b) is arranged as a voltage
follower for the electrophysiology signal. The system flips
between Ephys and Echem mode by CMOS analog switch
(SW1) MAX 319CSA (Texas Instruments, Dallas, TX) that
is triggered by a digital “Relay In” signal. Particular care has
been taken to select CMOS switches that have been optimized
for low leakage, low charge transfer, low and matched in-
put capacitance, and low noise. Because typical I-E converter
transconductance gains vary from 1V/μA to 1V/10 nA (RF
values of 1 M to 100 M) depending on the application, and
because the redox currents are on the order of nanoamperes or
less, leakage currents for the CMOS switches in the off state
must be far below these levels. We chose the MAX 319CSA
CMOS switch for the use on the headstage. It has leakage cur-
rent 250 pA and open resistance below 20 . Charge trans-
fer from the CMOS switch control line into the inputs and
FIG. 4. (Color online) Photo of miniaturized headstage used for combined
Echem/Ephys freely moving experiments adjacent to a U.S dime. The orange
and yellow connecting wires are for reference and working electrodes. The
copper connectors on the right are for bipolar stimulating electrode. One of
the SO chips is the analog switch and the other is the op amps. The cable on
the left of the printed circuit board leads to a DB-25 connector.
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FIG. 5. Circuitry for headstage used for combined Echem/Ephys freely moving experiments. The operational amplifiers, switch, resistors and capacitors are all
on a single printed circuit board (Fig. 4). The outputs and inputs on the right hand side of the diagram are interfaced through a DB-25 connector.
outputs must also be low in order to avoid amplifier saturation
during switching. The CMOS switch open and closed termi-
nal capacitances need to be low and relatively well matched to
minimize excess charging currents during the switching pro-
cess. For MAX 319CSA, on and off capacitances match and
are equal to 8 pF. In addition, the analog path noise of the
CMOS switch is of concern since the switches work on the
input side of the amplifier and therefore contribute directly to
the total circuit noise.
D. Design of the UEI chassis
The supporting electronics for the headstage reside in the
main UEI chassis. In present models, a low noise linear regu-
lated power supply for all of the circuitry needed for FSCV
and electrophysiological measurements is housed in a sep-
arate chassis. This separate chassis is located at a distance
from the mainframe in order to reduce electromagnetic noise
coupled from the transformer to sensitive circuitry. The UEI
mainframe has a backplane for inserting various support mod-
ules. This allows for maximum flexibility in construction of
multi-channel systems, addition of filtering hardware, and ad-
dition of future enhancements. In the simplest case, two plug-
in modules are used. One module contains additional vari-
able post-amplification for both the electrochemical and the
electrophysiological signals and routes signals to and from
the headstage. The second module is used for analog low
pass filtering of the digitized triangular signal before it is di-
rected to the headstage. The filter removes the staircase transi-
tions from the ADC output which can noise due to unwanted
C*dV/dt charging of the electrode capacitance at each tran-
sition. Other plug-in modules consist of a video text module
that synchronizes real-time video with the control software
and multi-channel FSCV modules.
1. Electronic design for switching control module
The switching control modules alternate between the
Ephys and Echem mode of operation.29 Switching is triggered
by a “Relay In” signal that is received from the computer via a
BNC on the front panel of the UEI instrument. Analog CMOS
switches U5 (SW2 and SW5) and U2 (SW3 and SW4) are
MAX 314 CMOS switches (DIP, Maxim, Sunnyvale, CA),
that have a rapid (>1 μs) switching time with low (10 )
on-resistance.
In Echem mode, the I/E signal received from the head-
stage is sent to the electrochemical amplifier. The triangular
wave (Ramp In) is computer generated and received from
BNC connector on UEI front panel and sent to the head-
stage (Ramp Out). In Echem mode, the “Ephys In” signal
from the headstage, the output to the spike amplifier (Ephys
Out to Amp), and the “Ephys Out” to UEI front panel are
all grounded. In Ephys mode, the “Ephys In” signal received
from the headstage is sent to the spike amplifier. Afterwards,
it is sent out on front panel BNC “Ephys Out”. Voltammetric
ramp (Ramp In), electrochemical input from the headstage
(I/E In) and input to electrochemical amplifier (I/E Out to
Amp) are disconnected. A “RELAY IN” LED on the front
panel notifies the user whenever the system switches to the
Ephys state and it is controlled by circuitry shown on the right
bottom corner.29
2. Electronic design of the electrochemical amplifier
with variable gain
The voltammetric signal is received from the switching
control model after being amplified on the headstage and it
is further amplified with variable gain.29 The main amplifier
U2a is based on dual low noise LT1113 chip (Linear Technol-
ogy, Milpitas, CA). The gain of this amplifier can be chosen
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using push buttons on UEI front panel (K3, K4, and K5) and
can be set to X1, X2, X5, and X10 multiplies of the headstage
gain. Front panel LEDs mark the gain selected. A CD4017
(National instruments, Austin, TX) counter chip is used to
control the LEDs and switch the gain.
To notify the user about overload in I/E signal, an over-
load detector is constructed with U5a and U5b, which are
LM393 low power low voltage dual comparator (National
Semiconductors, Santa Clara, CA). In a case of an overload,
a red LED on the front panel illuminates when the I/E current
exceeds the amplifier output limit.
The LED “on” time is controlled with dual precision
monostable CD4538 (National Semiconductors, Santa Clara,
CA). After being processed through the first amplifier, the
I/E signal is buffered through the second LT1113 chip
(U2b) and sent out through a BNC connector on UEI front
panel.
3. Electronic design of the spike amplifier
The electrophysiological signal from neurons (spikes) is
received from the switching control module. Amplification of
this Ephys signal is done by an OP27 (Analog Devices, Nor-
wood, MA) low-noise precision operational amplifier.29 The
signal is amplified by two amplifiers with high gain, U1 and
U2 (resistors R5, R12, and capacitors C3, C4). Adjustable
high pass filtering is employed to remove the DC component
(“Front Panel RC”). Overload can latch amplifiers used with
high gain. To prevent it, diode pairs (D1, D2, D3, and D4)
are used to limit the maximum input voltage to ±0.6 V. After
being processed through the second U2 amplifier, the Ephys
signal is sent back to switching control module. Switching is
utilized on the Ephys signal because active gating is not al-
ways available on the various third party hardware used for
spike processing (i.e., Plexon).
III. CONCLUSIONS
FSCV combined with single-unit electrophysiology is a
powerful technique for studying the dopaminergic system on
both the presynaptic and post-synaptic side. The instrument
allows chemical and electrical information to be obtained at a
single location within the brain. Application of this technique
in behaving animals is of particular interest.
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